期刊文献+

miR-182通过HES1调控宫颈癌耐放疗细胞株的上皮间质转化 被引量:2

miR-182 attenuates EMT of radioresistant cervical cancer cells by targeting HES1
下载PDF
导出
摘要 目的探讨miR-182在宫颈癌耐放疗细胞株中的作用及其调控方式。方法采用分割剂量照射法诱导宫颈癌耐放疗HeLa细胞株和SiHa细胞株,分别每周4 Gy照射1次(HR4组和SR4组)和每周6 Gy照射1次(HR6组和SR6组)。采用RT-qPCR和Western blot检测4株耐放疗细胞中发状分裂相关增强子1(hairy and enhancer of split 1,HES1)和miR-182的表达。在筛选的耐放疗HR6细胞中下调miR-182后,检测该细胞中上皮间质转化相关因子E-cadherin、Slug mRNA和蛋白的表达,Transwell小室法检测细胞迁移和侵袭能力;并观察耐放疗HR6细胞中miR-182与HES1相互表达的影响。结果与未照射宫颈癌HeLa和SiHa细胞比较,耐放疗HeLa和SiHa细胞中HES1表达均显著降低(P<0.05),miR-182表达显著升高(P<0.05),且在不同耐放疗细胞株中miR-182表达有差异性(P<0.05)。下调miR-182后,HR6细胞中E-cadherin表达增强,Slug表达降低,且细胞迁移、侵袭能力减弱。HR6细胞中miR-182下调后HES1表达升高,但下调HES1后miR-182表达无明显变化。结论宫颈癌耐放疗细胞中下调miR-182可上调HES1,从而逆转上皮间质转化并抑制细胞迁移、侵袭,HES1可能是miR-182发挥作用的靶点。 Objective To evaluate the effect of miR-182 in radioresistant cervical caner cells and its probable regulative mode.Methods HeLa cell lines and SiHa cell lines were induced by fractionated dose irradiation,respectively,once a week at 4 Gy(HR4 group and SR4 group) and once a week at 6 Gy(HR6 group and SR6 group). Expression of HES1 and miR-182 in 4 radiation resistant cells were detected using RT-qPCR and Western blotting.The expression levels of epithelial-mesenchymal transition-(EMT-) related factors(E-cadherin,Slug) were detected after down-regulation of miR-182 in selected radioresistant HR6 cells,and the capability of invasion and migration of HR6 cells was measured using the transwell assay. Additionally,we separately knocked down miR-182 or HES1 and investigated their ralationship. Results HES1 were significantly reduced in HeLa and SiHa cells after radiation,while miR-182 were significantly increased. Levels of miR-182 were diverse in different radioresistant cells. Knockdown of miR-182 significantly increased E-cadherin,decreased Slug in HR6 HeLa cells,and silenced their migration and invasion. The expression of HES1 in HR6 cells was increased after miR-182 knockdown,while the knockdown of HES1 did not affect miR-182. Conclusions Silencing miR-182 can effectively inverse EMT and inhibit migration and invasion by radioresistant cervical cancer cells. miR-182 may exert these effects by regulating the expression of HES1.
作者 李睿歆 谢庆生 王丽娟 李晶 饶群仙 林仲秋 Li Ruixin;Xie Qingsheng;Wang Lijuan;Li Jing;Rao Qunxian;Lin Zhongqiu(Department of Gynecologic Oncology,Sun Yat-Sen Memorial Hospital,Sun Yat-Sen University,Guangzhou 510120,China)
出处 《中国癌症防治杂志》 CAS 2018年第4期278-282,共5页 CHINESE JOURNAL OF ONCOLOGY PREVENTION AND TREATMENT
关键词 子宫肿瘤 放疗耐受 miR-182 HES1 上皮间质转化 转移 Cervical neoplasms Radioresistance miR-182 HES1 Epithelial-mesenchymal transition Migration
  • 相关文献

参考文献2

二级参考文献14

  • 1De Bacco F,Luraqhi P,Medico E,et al.Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer[J].J Natl Cancer Inst,2011,103(8):645-661.
  • 2Hittelman WN,Liao Y,Wang L,et al.Are cancer stem cells radioresistant[J]?Future Oncol,2010,6(10):1563-1576.
  • 3Feng D,Peng C,Li C,et al.Identification and characterization of cancer stem-like cells from primary carcinoma of the cervix uteri[J].Oncol Rep,2009,22(5):1129-1134.
  • 4Mihatsch J,Toulany M,Bareiss PM,et al.Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro[J].Radiother Oncol,2011,99(3):300-306.
  • 5Gupta PB,Chaffer CL,Weinberg RA.Cancer stem cells:mirage or reality?[J].Nat Med,2009,15(9):1010-1012.
  • 6Achary MP,Jaggernauth W,Gross E,et al.Cell lines from the same cervical carcinoma but with different radiosensitivities exhibit different cDNA microarray patterns of gene expression[J].Cytogenet Cell Genet,2000,91(1-4):39-43.
  • 7Singh SK,Clarke ID,Terasaki M,et al.Identification of a cancer stem cell in human brain tumors[J].Cancer Res,2003,63(18):5821-5828.
  • 8Qing Y,Yang XQ,Zhong ZY,et al.Microarray analysis of DNA damage repair gene expression profiles in cervical cancer cells radioresistant to 252Cf neutron and X-ray[J].BMC Cancer,2010,10:71.
  • 9Pawlik TM,Keyomarsi K.Role of cell cycle in mediating sensitivity to radiotherapy[J].Int J Radiat Oncol Biol Phys,2004,59(4):928-942.
  • 10Bentzen SM.Preventing or reducing late side effects of radiation therapy:radiabology meets molecular pathology[J].Nat Rev Cancer,2006,6(9):702-713.

共引文献4

同被引文献20

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部